SCHEMBL8017282

SCHEMBL8017282

C1CCC(C2CCNC2)C1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.47
CCR5 P51681 1/20 0.37
HTR2C P28335 1/20 0.35
HTR6 P50406 1/20 0.34
HTR3A P46098 1/20 0.32
SLC6A1 P30531 3/20 0.31
SLC6A11 P48066 2/20 0.31
SLC6A13 Q9NSD5 2/20 0.31
KCNH2 Q12809 1/20 0.31
TSHR P16473 1/20 0.31
LMNA P02545 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
PNMT P11086 1/20 0.30
APLNR P35414 2/20 0.30
KDM4E B2RXH2 1/20 0.30
MAPT P10636 1/20 0.30
KMT2A Q03164 1/20 0.30
ATM Q13315 1/20 0.30
NOS2 P35228 1/20 0.30
CYP2D6 P10635 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5114077 1.00 ALDH1A1 (0.47) ALDH1A1CCR5HTR2CHTR6HTR3A
SCHEMBL1037842 1.00 ALDH1A1 (0.47) ALDH1A1CCR5HTR2CHTR6HTR3A
SCHEMBL14620877 1.00 ALDH1A1 (0.47) ALDH1A1CCR5HTR2CHTR6HTR3A
SCHEMBL6426932 1.00 ALDH1A1 (0.47) ALDH1A1CCR5HTR2CHTR6HTR3A
SCHEMBL165540 1.00 ALDH1A1 (0.47) ALDH1A1CCR5HTR2CHTR6HTR3A
SCHEMBL24912524 1.00 ALDH1A1 (0.47) ALDH1A1CCR5HTR2CHTR6HTR3A
SCHEMBL14772 1.00 ALDH1A1 (0.47) ALDH1A1CCR5HTR2CHTR6HTR3A
SCHEMBL1037843 1.00 ALDH1A1 (0.47) ALDH1A1CCR5HTR2CHTR6HTR3A
SCHEMBL22540086 1.00 ALDH1A1 (0.47) ALDH1A1CCR5HTR2CHTR6HTR3A
SCHEMBL12440357 1.00 ALDH1A1 (0.47) ALDH1A1CCR5HTR2CHTR6HTR3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4618755-A1 INHIBITORS AND DEGRADERS OF PIP4K PROTEIN Larkspur Biosciences, Inc. (US) 2025-09-24 EP disclosed
WO-2024107746-A1 INHIBITORS AND DEGRADERS OF PIP4K PROTEIN LARKSPUR BIOSCIENCES (US) 2024-05-23 WO disclosed
EP-3591052-B1 RESTORATION OF THE CFTR FUNCTION BY SPLICING MODULATION YISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD (IL) 2023-08-30 EP disclosed
EP-4108781-A1 CONDITIONAL PRIMER EXTENSION FOR SINGLE-MOLECULE DETECTION President and Fellows of Harvard College (US) 2022-12-28 EP disclosed
US-10759777-B2 Carbazole-containing amides, carbamates, and ureas as cryptochrome modulators Synchronicity Pharma, Inc. (US) 2020-09-01 US disclosed
US-20190241540-A1 CARBAZOLE-CONTAINING AMIDES, CARBAMATES, AND UREAS AS CRYPTOCHROME MODULATORS Synchronicity Pharma, Inc. 2019-08-08 US disclosed
WO-2000031020-A1 IMPROVED GAMMA AMINO BUTYRIC ACID ANALOGS WARNER-LAMBERT COMPANY (US) 2000-06-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190241540-A1 CARBAZOLE-CONTAINING AMIDES, CARBAMATES, AND UREAS AS CRYPTOCHROME MODULATORS CRY1, CRY2, HCCS ALDH1A1 2882/4885CCR5 1350/4885HTR2C 2250/4885
US-10759777-B2 Carbazole-containing amides, carbamates, and ureas as cryptochrome modulators CRY1, CRY2, HCCS ALDH1A1 2882/4885CCR5 1350/4885HTR2C 2250/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.